ananthi, Author at Sun Pharmaceutical Industries Ltd. - Page 5 of 7

AstraZeneca and Sun Pharma partner to help patients living with Hyperkalemia in India

AstraZeneca and Sun Pharma partner to help patients living with Hyperkalemia in India

by ananthi | Nov 17, 2025 | Uncategorized

Read More

Sun Pharma launches ‘#SeeBeyondSugar’ campaign on World Diabetes Day: A nation-wide initiative to raise awareness about Diabetic Retinopathy

Sun Pharma launches ‘#SeeBeyondSugar’ campaign on World Diabetes Day: A nation-wide initiative to raise awareness about Diabetic Retinopathy

by ananthi | Nov 14, 2025 | Uncategorized

Read More

Sun Pharma reports Q2FY26 results

Sun Pharma reports Q2FY26 results

by ananthi | Nov 5, 2025 | Press Releases

Read More

AstraZeneca and Sun Pharma partner to help patients living with Hyperkalemia in India

Sun Pharma reports Q1FY26 results

by ananthi | Jul 31, 2025 | Press Releases

Read More

Sun Pharma’s Phase 3 Clinical Studies Evaluating Tildrakizumab 100 mg (ILUMYA) in Active Psoriatic Arthritis Meet their Primary Endpoint

Sun Pharma’s Phase 3 Clinical Studies Evaluating Tildrakizumab 100 mg (ILUMYA) in Active Psoriatic Arthritis Meet their Primary Endpoint

by ananthi | Jul 21, 2025 | Press Releases

Read More

« Older Entries

Next Entries »

Top